BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 990 filers reported holding BAXTER INTL INC in Q4 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,270,246 | -21.2% | 86,652 | -4.9% | 0.01% | -16.7% |
| Q2 2023 | $4,150,425 | +5.0% | 91,098 | -6.5% | 0.01% | 0.0% |
| Q1 2023 | $3,951,801 | -12.3% | 97,431 | +10.2% | 0.01% | -25.0% |
| Q4 2022 | $4,508,297 | -5.4% | 88,450 | -0.1% | 0.02% | -11.1% |
| Q3 2022 | $4,766,000 | -23.9% | 88,522 | -9.2% | 0.02% | -14.3% |
| Q2 2022 | $6,259,000 | -37.3% | 97,447 | -24.4% | 0.02% | 0.0% |
| Q1 2022 | $9,990,000 | -11.8% | 128,835 | -2.4% | 0.02% | -4.5% |
| Q4 2021 | $11,329,000 | +40.2% | 131,978 | +31.4% | 0.02% | -4.3% |
| Q3 2021 | $8,081,000 | -7.2% | 100,472 | -7.1% | 0.02% | -8.0% |
| Q2 2021 | $8,704,000 | +16.2% | 108,119 | +21.8% | 0.02% | +4.2% |
| Q1 2021 | $7,489,000 | +8.2% | 88,801 | +3.0% | 0.02% | -7.7% |
| Q4 2020 | $6,920,000 | +7.8% | 86,242 | +8.1% | 0.03% | -13.3% |
| Q3 2020 | $6,417,000 | -5.0% | 79,795 | +1.7% | 0.03% | -16.7% |
| Q2 2020 | $6,755,000 | +1.1% | 78,456 | -4.7% | 0.04% | -25.0% |
| Q1 2020 | $6,683,000 | -37.8% | 82,315 | -35.9% | 0.05% | -4.0% |
| Q4 2019 | $10,745,000 | +14.0% | 128,501 | +19.3% | 0.05% | -5.7% |
| Q3 2019 | $9,423,000 | +12.0% | 107,727 | +4.9% | 0.05% | +6.0% |
| Q2 2019 | $8,415,000 | -12.0% | 102,743 | -12.7% | 0.05% | -12.3% |
| Q1 2019 | $9,565,000 | +22.1% | 117,633 | -1.2% | 0.06% | +3.6% |
| Q4 2018 | $7,834,000 | -12.4% | 119,019 | +2.6% | 0.06% | -9.8% |
| Q3 2018 | $8,941,000 | +1.4% | 115,980 | -2.9% | 0.06% | +3.4% |
| Q2 2018 | $8,818,000 | +7.8% | 119,416 | -5.0% | 0.06% | +11.3% |
| Q1 2018 | $8,177,000 | +4.5% | 125,724 | +3.9% | 0.05% | -1.9% |
| Q4 2017 | $7,822,000 | +27.8% | 121,002 | +24.1% | 0.05% | -3.6% |
| Q3 2017 | $6,120,000 | +12.4% | 97,535 | +8.4% | 0.06% | +3.7% |
| Q2 2017 | $5,445,000 | +12.6% | 89,948 | -3.5% | 0.05% | +5.9% |
| Q1 2017 | $4,836,000 | +15.6% | 93,255 | -1.1% | 0.05% | +10.9% |
| Q4 2016 | $4,183,000 | +20.8% | 94,338 | +29.7% | 0.05% | -4.2% |
| Q3 2016 | $3,463,000 | -23.2% | 72,745 | -27.0% | 0.05% | -17.2% |
| Q2 2016 | $4,508,000 | +9.8% | 99,693 | -0.3% | 0.06% | +1.8% |
| Q1 2016 | $4,106,000 | -21.7% | 99,963 | -27.3% | 0.06% | -10.9% |
| Q4 2015 | $5,247,000 | +20.2% | 137,545 | +3.5% | 0.06% | +4.9% |
| Q3 2015 | $4,366,000 | -47.8% | 132,917 | +11.1% | 0.06% | -47.4% |
| Q2 2015 | $8,370,000 | -11.8% | 119,687 | -13.6% | 0.12% | +3.6% |
| Q1 2015 | $9,487,000 | -8.8% | 138,494 | -2.5% | 0.11% | -7.4% |
| Q4 2014 | $10,406,000 | +25.1% | 141,983 | +22.5% | 0.12% | +10.0% |
| Q3 2014 | $8,319,000 | -5.1% | 115,914 | -4.4% | 0.11% | -3.5% |
| Q2 2014 | $8,769,000 | +7.3% | 121,280 | +9.2% | 0.11% | +11.8% |
| Q1 2014 | $8,171,000 | +14.1% | 111,051 | +7.8% | 0.10% | -4.7% |
| Q4 2013 | $7,164,000 | +109.4% | 103,004 | +97.8% | 0.11% | +32.1% |
| Q3 2013 | $3,421,000 | -44.0% | 52,083 | -40.9% | 0.08% | -32.5% |
| Q2 2013 | $6,109,000 | – | 88,190 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |